Lanean...
Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis
BACKGROUND: We performed a meta-analysis of cholinesterase inhibitors for patients with Lewy body disorders, such as Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies. METHODS: The meta-analysis included only randomized controlled trials of cholinesterase inhibitors fo...
Gorde:
| Argitaratua izan da: | Int J Neuropsychopharmacol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772820/ https://ncbi.nlm.nih.gov/pubmed/26221005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyv086 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|